Compare two pelvic floor stimulation devices to see which helps with urinary incontinence in women
Official title: Randomized Clinical Trial: Electromagnetic Chair Therapy in Female Mixed Urinary Incontinence Compared to Standard Care (Electrostimulation With Biofeedback)
Run by Espacio Gaspar Clinic · NCT07792031 · Data updated 2026-11-12
We’re testing if electromagnetic chair therapy can help women with mixed urinary incontinence as well as standard electrostimulation with biofeedback.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 58 (estimated) |
| Sponsor | Espacio Gaspar Clinic Academic / other |
| Locations | 2 sites (Mendoza and 1 other locations) |
| Status | Recruiting |
| Started | October 20, 2026 |
| Main results expected | September 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT07792031 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with a confirmed diagnosis of mixed urinary incontinence for at least 3 months, treatment-naive or not recently treated.
✕Probably not a fit
Patients with active urinary tract infection, advanced pelvic organ prolapse, recent childbirth, prior incontinence surgery, or contraindications to electromagnetic stimulation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, parallel-group, non-inferiority study will enroll 58 adult women with mixed urinary incontinence, randomizing them 1:1 to receive 12 treatment sessions over six weeks. One group will use the StarFormer electromagnetic chair, and the other will receive standard pelvic-floor electrostimulation with biofeedback. Outcomes will be measured at baseline, week 6, and week 30, with the primary endpoint being the change in average daily urinary incontinence episodes over a three-day bladder diary from baseline to week 6. Secondary outcomes include changes in urgency and stress incontinence episodes, voiding frequency, nocturia, pad use, ICIQ-UI SF scores, patient-reported improvement, responder rates, and urodynamic parameters, along with safety and adherence assessments.
Why it matters
Potential benefit: If successful, the approach could offer an effective non-invasive option for reducing urinary leakage and improving quality of life for women with mixed incontinence.
How similar studies have gone: Prior pelvic-floor stimulation studies show promise for symptom improvement, but this direct non-inferiority comparison with an electromagnetic chair is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women ≥ 18 years of age. * Diagnosis of mixed urinary incontinence according to the operational definition. * Symptom duration ≥ 3 months. * Minimum severity: ≥ 2 total incontinence episodes documented in the baseline 3-day bladder diary up to 5 incontinence episodes * Treatment-naive: * With no pharmacologic treatment for OAB/UI in the previous 8 weeks. * With no supervised pelvic floor rehabilitation, electrical stimulation, PTNS, neuromodulation, or prior electromagnetic chair therapy (preferably never, for population homogeneity). * Ability to complete bladder diaries and questionnaires and attend scheduled visits (and all 12 treatment sessions). * Signed informed consent. Exclusion Criteria: * Active or suspected unresolved urinary tract infection (urinalysis ± culture according to local practice; first episode). * Uninvestigated macroscopic hematuria. * Advanced pelvic organ prolapse (POP-Q stage III-IV). * Pregnancy or postpartum \< 2 months. * Major neurological disease affecting bladder or urethral function.
Where it's running
-
Espacio Gaspar
Mendoza, Argentina Recruiting -
Uroclinica
Mendoza, Argentina Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing tissue elasticity in women with urinary incontinence
This study is testing a new way to see if the stiffness of tissue around the urethra can help doctors better diagnose stress urinary incontinence in women.
-
Urinary incontinence in older adults: how leakage and bladder residuals relate to frailty
This study tests whether the severity of urinary leakage and leftover urine after voiding are linked to frailty and other geriatric outcomes in older adults visiting a urology clinic.
-
Trampoline effects on pelvic support and urine leakage
This study will try a 10-minute high-intensity trampoline session to see if it causes urine leakage or short-term changes in pelvic floor structure in active women aged 18–40 who do not usually leak.
-
Personalized pudendal nerve stimulation for mixed urinary incontinence and pelvic pain
This trial will try personalized pudendal nerve stimulation with an implanted Picostim II device to reduce leakage and pelvic pain in adult women with mixed urinary incontinence who haven't improved with conservative treatments.
-
Comparing two treatments for stress urinary incontinence in women
This study is testing which treatment, a special gel injection or a small surgical sling, works better for women dealing with stress urinary incontinence.
-
Kinesthetic Pelvic Floor Imagery Added to Exercises for Stress Urinary Incontinence
In postmenopausal women with stress urinary incontinence, this study tests whether mentally rehearsing pelvic floor muscle contractions before doing the exercises helps reduce leakage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.